Skip to content
Resources > Reports

ESG and Sustainability Trends in C-Suite in 2023

Following another year of increasing focus on environmental, social, and governance (ESG) considerations by companies, investors, and regulators alike, ESG appears to have cemented its position in the corporate landscape.

We know most companies today are making serious ESG investments. But to what extent is the C-Suite really updating shareholders on sustainability topics? Which industries are discussing ESG, and more importantly, which ones are staying silent?

In this report, we analyze and break down earnings transcripts from 2023 that are driving ESG in 2024 and beyond:

  • The ESG topics that are top-of-mind for C-Suite and which have been surprisingly deprioritized
  • How sustainability compares to other business topics like ethics and cybersecurity
  • Which industries are most committed to ESG and which are not
  • Key trends to watch like mandatory regulatory uptakes, M&A deal cycles, and artificial intelligence.

Explore more

APAC Macro Briefing 2026: Risk Meets Opportunity

In this report, we show how resources and workflows available in the AlphaSense platform can help contextualize the APAC macro environment, exploring the key implications for corporate leaders and investors across sectors.
Title slide for "APAC Macro Briefing 2026: Risk Meets Opportunity" with a map of the Asia-Pacific region.

Top AI Use Cases for Private Equity

In this report, discover how private equity teams are leveraging AI to accelerate conviction with speed. With purpose built, AI-driven solutions like AlphaSense, teams are gaining a competitive advantage with custom workflows and unmatched content sets for the most differentiated deal intelligence.
Top AI Use Cases For Private Equity by Barb Tague, Financial Research Leader. Illustration featuring isometric buildings and currency symbols.

AI in Drug Development 2026: From Experimentation to Execution

Learn how AI is reshaping drug development in real time, turning AI execution into a key competitive differentiator.
Presentation slide titled "AI in Drug Development 2026: From Experimentation to Execution" by Sara Mallatt and Sean Carmichael, with line art of laboratory equipment.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.